Private Market View

CellCentric

Biotechnology · Cambridge, United Kingdom · Founded 2003 · Privately Held (backing)

PA Mark · $/share
$5
Sep 2026
Implied valuation
$382.5M
Total raised
$280.5M
Last round
Later Stage VC (Series C)
Apr 2025
Cap table — not yet on record

CellCentric's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·The complete investor list — 20 names
  • ·Watchlist + deal alerts for CellCentric
Create free account
No card required

Frequently asked

Where does CellCentric's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across CellCentric's 2 recorded funding rounds.